ReviewExpert opinion on therapeutic targets2014

Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders.

Shang-Yi A Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.